Expression of E-cadherin, P-cadherin and β-catenin in canine malignant mammary tumours in relation to clinicopathological parameters, proliferation and survival

被引:60
作者
Gama, Adelina [2 ]
Paredes, Joana [1 ,3 ]
Gartner, Fatima [1 ,4 ]
Alves, Anabela [2 ]
Schmitt, Fernando [1 ,3 ,5 ]
机构
[1] Univ Porto, Inst Mol Pathol & Immunol, IPATIMUP, P-4200465 Oporto, Portugal
[2] Univ Tras os Montes & Alto Douro, Dept Vet Sci, P-5001911 Vila Real, Portugal
[3] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst, Braga, Portugal
[4] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4099003 Oporto, Portugal
[5] Univ Porto, Fac Med, P-4200465 Oporto, Portugal
关键词
canine; mammary tumours; E-cadherin; P-cadherin; beta-catenin;
D O I
10.1016/j.tvjl.2007.05.024
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Cadherin-catenin complexes play a critical role in intercellular adhesion, and their altered expression has been implicated in tumour progression. In this study, the expression of E-cadherin, P-cadherin and beta-catenin was analysed in 65 canine malignant mammary tumours and correlated with clinicopathological parameters, proliferation and survival. Reduction in E-cadherin expression was significantly associated with increased tumour size, high histological and invasion grades, lymph node metastasis and high mitotic index. Reduced beta-catenin expression was associated with high histological and invasion grades. Anomalous expression of P-cadherin was only associated with invasion. In 39 cases for which follow-up data were available, reduced E-cadherin and beta-catenin expression was significantly associated with shorter overall survival and disease free survival. Abnormal expression of adhesion molecules is a common phenomenon in canine mammary malignant tumours and may play a central role in tumour progression. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 42 条
  • [1] Bànkfalvi A, 1999, HISTOPATHOLOGY, V34, P25
  • [2] E-cadherin and β-catenin reduction influence invasion but not proliferation and survival in canine malignant mammary tumors
    Brunetti, B
    Sarli, G
    Preziosi, R
    Monari, I
    Benazzi, C
    [J]. VETERINARY PATHOLOGY, 2005, 42 (06) : 781 - 787
  • [3] Bukholm IK, 1998, J PATHOL, V185, P262, DOI 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO
  • [4] 2-Y
  • [5] Charpin C, 1999, INT J ONCOL, V15, P285
  • [6] Quantitative in situ analysis of β-catenin expression in breast cancer shows decreased expression is associated with poor outcome
    Dolled-Filhart, Marisa
    McCabe, Anthony
    Giltnane, Jennifer
    Cregger, Melissa
    Camp, Robert L.
    Rimm, David L.
    [J]. CANCER RESEARCH, 2006, 66 (10) : 5487 - 5494
  • [7] ELSTON CW, 1998, SYSTEMIC PATHOLOGY B, P365
  • [8] E-cadherin, β-catenin, mivasion and lymph node metastases in canine malignant mammary tumours
    Ferreira De Matos, Augusto Jose
    Carreiras Lopes, Celia Cristina
    Rodrigues Faustino, Augusto Manuel
    Vale Carvalheira, Julio Gil
    Rutteman, Gerard Roel
    Rodrigues Moutinho Gartner, Maria De Fatima
    [J]. APMIS, 2007, 115 (04) : 327 - 334
  • [9] Relationship between E-cadherin gene mutation and p53 gene mutation, p53 accumulation, Bcl-2 expression and Ki-67 staining in diffuse-type gastric carcinoma
    Fricke, E
    Keller, G
    Becker, I
    Rosivatz, E
    Schott, C
    Plaschke, S
    Rudelius, M
    Hermannstädter, C
    Busch, R
    Höfler, H
    Becker, KF
    Luber, B
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (01) : 60 - 65
  • [10] P-cadherin expression in canine mammary tissues
    Gama, A
    Paredes, J
    Albergaria, A
    Gartner, R
    Schmitt, F
    [J]. JOURNAL OF COMPARATIVE PATHOLOGY, 2004, 130 (01) : 13 - 20